Dr. Grumezescu is Assistant Professor at the Department of Science and Engineering of Oxide Materials and Nanomaterials, in the Faculty of Applied Chemistry and Materials Science, with a second affiliation to the Faculty of Medical Engineering, at the Politehnica University of Bucharest in Romania. He is an experienced and oft-published researcher and editor in the field of nano and biomaterials, and he is the Editor-in-Chief of three journals: Biointerface Research in Applied Chemistry, Letters and Applied NanoBioScience, and Biomaterials and Tissue Engineering Bulletin. He also serves as editor or guest editor for several notable journals. Dr. Grumezescu has published 150 peer-reviewed papers, 20 book chapters, 6 co-authored books and 11 edited books. Prof. Anton Ficai is Professor and PhD advisor in the Faculty of Chemical Engineering and Biotechnologies at the National University of Science and Technology POLITEHNICA Bucharest, Romania. He is deeply involved in academic and research activities, coordinating courses in Chemistry, Materials Characterization, Composite Materials for Medicine, and NanoBioMaterials for Tissue Engineering and Drug Delivery. His research covers tissue engineering, drug delivery systems, multifunctional and composite materials, antimicrobial and antitumoral coatings, nanoparticle synthesis, and surface modification. He has published over 350 scientific papers—including more than 330 ISI-indexed works—and 23 books or chapters, and he holds 30 patent applications, 10 of which are granted. Internationally recognized, he frequently serves as an invited speaker, guest editor, editorial board member, and Section Editor-in-Chief of Coatings. A valedictorian of UPB and laureate of national chemistry competitions, he has received over 100 awards and is an active member of the Academy of Romanian Scientists.

• 1. Nanotechnology for personalized medicine: cancer research, diagnosis, and therapy2. Bioengineered nanomaterials for chemotherapy3. Biofunctionalized nanomaterials for targeting cancer cells4. Improving chemotherapy drug delivery by nanoprecision tools5. RIPL peptide as a novel cell-penetrating and homing peptide: design, characterization, and application to liposomal nanocarriers for hepsin-specific intracellular drug delivery6. Progress of nanoparticles research in cancer therapy and diagnosis7. Interfacial engineering of nanoparticles for cancer therapeutics8. Nanotechnological approaches toward cancer chemotherapy9. Cancer therapies: applications, nanomedicines and nanotoxicology10. Multifunctional polymeric micelles as therapeutic nanostructures: targeting, imaging, and triggered release 11. Recent advances in diagnosis and therapy of skin cancers through nanotechnological approaches12. Design of nanoparticle structures for cancer immunotherapy13. Recent advances of folate-targeted anticancer therapies and diagnostics: current status and future prospectives14. Anticancer efficiency of curcumin-loaded invertible polymer micellar nanoassemblies15. Dose enhancement effect in radiotherapy: adding gold nanoparticles to tumor in cancer treatment16. Silver-based nanostructures for cancer therapy17. Ligand-decorated polysaccharide nanocarriers for targeting therapeutics to hepatocytes18. Targeted delivery of anticancer drugs: new trends in lipid nanocarriers19. Nanoparticles for magnetic hyperthermia20. Nanotechnology: a challenge in hard tissue engineering with emphasis on bone cancer therapy21 Combination therapy of macromolecules and small molecules: approaches, advantages, and limitations22. Nanosized drug delivery systems as radiopharmaceuticals23. Mesoporous silica nanoparticles: a promising multifunctional drug delivery system24. Cancer therapies based on enzymatic amino acid depletion25. Self-emulsifying delivery systems: one step ahead in improving solubility of poorly soluble drugs26. Near-infrared light-responsive nanotherapeutic agents: application in medical oncology27. Current aspects of breast cancer therapy and diagnosis based on a nanocarrier approach28. Natural plant-derived anticancer drugs nanotherapeutics: a review on preclinical to clinical success29. Nanotherapy: a next generation hallmark for combating cancer30. Nanostructures for cancer therapy: from targeting to selective toxicology

Dr. Grumezescu is Assistant Professor at the Department of Science and Engineering of Oxide Materials and Nanomaterials, in the Faculty of Applied Chemistry and Materials Science, with a second affiliation to the Faculty of Medical Engineering, at the Politehnica University of Bucharest in Romania. He is an experienced and oft-published researcher and editor in the field of nano and biomaterials, and he is the Editor-in-Chief of three journals: Biointerface Research in Applied Chemistry, Letters and Applied NanoBioScience, and Biomaterials and Tissue Engineering Bulletin. He also serves as editor or guest editor for several notable journals. Dr. Grumezescu has published 150 peer-reviewed papers, 20 book chapters, 6 co-authored books and 11 edited books. Prof. Anton Ficai is Professor and PhD advisor in the Faculty of Chemical Engineering and Biotechnologies at the National University of Science and Technology POLITEHNICA Bucharest, Romania. He is deeply involved in academic and research activities, coordinating courses in Chemistry, Materials Characterization, Composite Materials for Medicine, and NanoBioMaterials for Tissue Engineering and Drug Delivery. His research covers tissue engineering, drug delivery systems, multifunctional and composite materials, antimicrobial and antitumoral coatings, nanoparticle synthesis, and surface modification. He has published over 350 scientific papers—including more than 330 ISI-indexed works—and 23 books or chapters, and he holds 30 patent applications, 10 of which are granted. Internationally recognized, he frequently serves as an invited speaker, guest editor, editorial board member, and Section Editor-in-Chief of Coatings. A valedictorian of UPB and laureate of national chemistry competitions, he has received over 100 awards and is an active member of the Academy of Romanian Scientists.

• 1. Nanotechnology for personalized medicine: cancer research, diagnosis, and therapy2. Bioengineered nanomaterials for chemotherapy3. Biofunctionalized nanomaterials for targeting cancer cells4. Improving chemotherapy drug delivery by nanoprecision tools5. RIPL peptide as a novel cell-penetrating and homing peptide: design, characterization, and application to liposomal nanocarriers for hepsin-specific intracellular drug delivery6. Progress of nanoparticles research in cancer therapy and diagnosis7. Interfacial engineering of nanoparticles for cancer therapeutics8. Nanotechnological approaches toward cancer chemotherapy9. Cancer therapies: applications, nanomedicines and nanotoxicology10. Multifunctional polymeric micelles as therapeutic nanostructures: targeting, imaging, and triggered release 11. Recent advances in diagnosis and therapy of skin cancers through nanotechnological approaches12. Design of nanoparticle structures for cancer immunotherapy13. Recent advances of folate-targeted anticancer therapies and diagnostics: current status and future prospectives14. Anticancer efficiency of curcumin-loaded invertible polymer micellar nanoassemblies15. Dose enhancement effect in radiotherapy: adding gold nanoparticles to tumor in cancer treatment16. Silver-based nanostructures for cancer therapy17. Ligand-decorated polysaccharide nanocarriers for targeting therapeutics to hepatocytes18. Targeted delivery of anticancer drugs: new trends in lipid nanocarriers19. Nanoparticles for magnetic hyperthermia20. Nanotechnology: a challenge in hard tissue engineering with emphasis on bone cancer therapy21 Combination therapy of macromolecules and small molecules: approaches, advantages, and limitations22. Nanosized drug delivery systems as radiopharmaceuticals23. Mesoporous silica nanoparticles: a promising multifunctional drug delivery system24. Cancer therapies based on enzymatic amino acid depletion25. Self-emulsifying delivery systems: one step ahead in improving solubility of poorly soluble drugs26. Near-infrared light-responsive nanotherapeutic agents: application in medical oncology27. Current aspects of breast cancer therapy and diagnosis based on a nanocarrier approach28. Natural plant-derived anticancer drugs nanotherapeutics: a review on preclinical to clinical success29. Nanotherapy: a next generation hallmark for combating cancer30. Nanostructures for cancer therapy: from targeting to selective toxicology

Dr. Grumezescu is Assistant Professor at the Department of Science and Engineering of Oxide Materials and Nanomaterials, in the Faculty of Applied Chemistry and Materials Science, with a second affiliation to the Faculty of Medical Engineering, at the Politehnica University of Bucharest in Romania. He is an experienced and oft-published researcher and editor in the field of nano and biomaterials, and he is the Editor-in-Chief of three journals: Biointerface Research in Applied Chemistry, Letters and Applied NanoBioScience, and Biomaterials and Tissue Engineering Bulletin. He also serves as editor or guest editor for several notable journals. Dr. Grumezescu has published 150 peer-reviewed papers, 20 book chapters, 6 co-authored books and 11 edited books. Prof. Anton Ficai is Professor and PhD advisor in the Faculty of Chemical Engineering and Biotechnologies at the National University of Science and Technology POLITEHNICA Bucharest, Romania. He is deeply involved in academic and research activities, coordinating courses in Chemistry, Materials Characterization, Composite Materials for Medicine, and NanoBioMaterials for Tissue Engineering and Drug Delivery. His research covers tissue engineering, drug delivery systems, multifunctional and composite materials, antimicrobial and antitumoral coatings, nanoparticle synthesis, and surface modification. He has published over 350 scientific papers—including more than 330 ISI-indexed works—and 23 books or chapters, and he holds 30 patent applications, 10 of which are granted. Internationally recognized, he frequently serves as an invited speaker, guest editor, editorial board member, and Section Editor-in-Chief of Coatings. A valedictorian of UPB and laureate of national chemistry competitions, he has received over 100 awards and is an active member of the Academy of Romanian Scientists.

• 1. Nanotechnology for personalized medicine: cancer research, diagnosis, and therapy2. Bioengineered nanomaterials for chemotherapy3. Biofunctionalized nanomaterials for targeting cancer cells4. Improving chemotherapy drug delivery by nanoprecision tools5. RIPL peptide as a novel cell-penetrating and homing peptide: design, characterization, and application to liposomal nanocarriers for hepsin-specific intracellular drug delivery6. Progress of nanoparticles research in cancer therapy and diagnosis7. Interfacial engineering of nanoparticles for cancer therapeutics8. Nanotechnological approaches toward cancer chemotherapy9. Cancer therapies: applications, nanomedicines and nanotoxicology10. Multifunctional polymeric micelles as therapeutic nanostructures: targeting, imaging, and triggered release 11. Recent advances in diagnosis and therapy of skin cancers through nanotechnological approaches12. Design of nanoparticle structures for cancer immunotherapy13. Recent advances of folate-targeted anticancer therapies and diagnostics: current status and future prospectives14. Anticancer efficiency of curcumin-loaded invertible polymer micellar nanoassemblies15. Dose enhancement effect in radiotherapy: adding gold nanoparticles to tumor in cancer treatment16. Silver-based nanostructures for cancer therapy17. Ligand-decorated polysaccharide nanocarriers for targeting therapeutics to hepatocytes18. Targeted delivery of anticancer drugs: new trends in lipid nanocarriers19. Nanoparticles for magnetic hyperthermia20. Nanotechnology: a challenge in hard tissue engineering with emphasis on bone cancer therapy21 Combination therapy of macromolecules and small molecules: approaches, advantages, and limitations22. Nanosized drug delivery systems as radiopharmaceuticals23. Mesoporous silica nanoparticles: a promising multifunctional drug delivery system24. Cancer therapies based on enzymatic amino acid depletion25. Self-emulsifying delivery systems: one step ahead in improving solubility of poorly soluble drugs26. Near-infrared light-responsive nanotherapeutic agents: application in medical oncology27. Current aspects of breast cancer therapy and diagnosis based on a nanocarrier approach28. Natural plant-derived anticancer drugs nanotherapeutics: a review on preclinical to clinical success29. Nanotherapy: a next generation hallmark for combating cancer30. Nanostructures for cancer therapy: from targeting to selective toxicology